SCHEMBL17854501

SCHEMBL17854501

CC1(C)c2ccccc2-c2ccc(N(c3ccc(-c4ccc5c(c4)-c4ccccc4C5(c4ccccc4)c4ccccc4)cc3)c3ccc4c(c3)C(c3ccccc3)(c3ccccc3)c3ccccc3-4)cc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.36
▸ LMNA P02545 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ OPRK1 P41145 1/20 0.36
▸ PDK2 Q15119 8/20 0.33
▸ ESR1 P03372 1/20 0.32
▸ ESR2 Q92731 1/20 0.32
▸ APAF1 O14727 1/20 0.30
▸ NPC1 O15118 1/20 0.30
▸ THRB P10828 1/20 0.30
▸ XBP1 P17861 1/20 0.30
▸ PTBP1 P26599 1/20 0.30
▸ HTT P42858 1/20 0.30
▸ RAB9A P51151 1/20 0.30
▸ GALK1 P51570 1/20 0.30
▸ BLM P54132 1/20 0.30
▸ SMAD3 P84022 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16802249 0.99 MEN1 (0.37) MEN1LMNAMAPTKMT2ASMN1; SMN2
SCHEMBL21392684 0.98 KDM4E (0.35) MEN1LMNAMAPTKMT2ASMN1; SMN2
SCHEMBL22480666 0.98 PDK2 (0.37) MEN1LMNAMAPTKMT2ASMN1; SMN2
SCHEMBL18468898 0.98 MEN1 (0.36) MEN1LMNAMAPTKMT2ASMN1; SMN2
SCHEMBL18468688 0.98 MEN1 (0.36) MEN1LMNAMAPTKMT2ASMN1; SMN2
SCHEMBL21923969 0.96 KDM4E (0.35) MEN1LMNAMAPTKMT2ASMN1; SMN2
SCHEMBL17854608 0.96 KDM4E (0.35) MEN1LMNAMAPTKMT2ASMN1; SMN2
SCHEMBL21923879 0.95 MEN1 (0.35) MEN1LMNAMAPTKMT2ASMN1; SMN2
SCHEMBL21559018 0.95 KDM4E (0.35) MEN1LMNAMAPTKMT2ASMN1; SMN2
SCHEMBL21392548 0.95 PDK2 (0.37) MEN1LMNAMAPTKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10944057-B2 Compound, material for organic electroluminescence devices, organic electroluminescence device, and electronic equipment IDEMITSU KOSAN CO., LTD. (JP) 2021-03-09 — — US disclosed
US-10854822-B2 Compound, material for organic electroluminescent element, organic electroluminescent element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2020-12-01 — — US disclosed
US-20180190904-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2018-07-05 — — US disclosed
US-20180190904-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2018-07-05 — — US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 — — US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 — — US disclosed
EP-3127894-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE Idemitsu Kosan Co., Ltd. (JP) 2017-02-08 — — EP disclosed
US-20160176801-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICES, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 — — US disclosed
US-20160176801-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICES, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10944057-B2 Compound, material for organic electroluminescence devices, organic electroluminescence device, and electronic equipment OR10J3, KCNA5, KCNK10 MEN1 796/4885LMNA 638/4885MAPT 2030/4885
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 MEN1 3297/4885LMNA 1423/4885MAPT 3500/4885
US-20180190904-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE ESR1, L1CAM, ELAVL1 MEN1 349/4885LMNA 527/4885MAPT 1833/4885
US-10854822-B2 Compound, material for organic electroluminescent element, organic electroluminescent element, and electronic device ESR1, L1CAM, ELAVL1 MEN1 349/4885LMNA 527/4885MAPT 1833/4885
US-20160176801-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICES, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT OR10J3, KCNA5, KCNK10 MEN1 796/4885LMNA 638/4885MAPT 2030/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback